A record-high number of Americans say they have tried a weight-loss drug, a new national poll from Gallup found. The survey ...

The new-age pharmaceutical landscape shows a growing reliance on customized, specialized therapies known to customers as compounded medicines. Compounding occurs when an approved and licensed ...

About one in nine Americans take a GLP-1 medication for weight loss, results from a new Gallup poll released on Tuesday found ...

Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, ...

According to internal financial records, the pharmacy dispensed nearly 3 million individual prescriptions to patients ...

The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey ...

Compounded semaglutide, meanwhile, contains the same active ingredient as Ozempic, semaglutide. However, this medication is not approved by the FDA, and it may pose risks to those who take it, ...

Big pharmaceutical companies argue that knock off GLP-1 drugs are misleading consumers and violating trade laws.

The state Medical Board accused a doctor and pharmacist of improperly manufacturing weight loss drugs out of a Sorrento Valley pain clinic.

Gallup: Weight-Loss Drug Use Nearly Quadruples ...

Tirzepatide is a dual GLP-1 and GIP receptor agonist that mimics two hormones in the gut that help regulate blood sugar, reduce hunger cues and slow digestion. It’s the active ingredient in the ...

PepScribe, a telehealth practice connecting patients with U.S.-licensed clinicians for personalized peptide and related ...